The markedly decreased Treg infiltration in murine ICC tumors after R428 treatment encouraged us to investigate whether combining R428 with anti–programmed cell death 1 (anti–PD-1) therapy could further inhibit tumor growth. This evidence concerns the gene PDCD1 and intrahepatic cholangiocarcinoma.